Status:
COMPLETED
THRIVE in Children at Different Flow Rates
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Apnea
Ventilation Therapy; Complications
Eligibility:
All Genders
1-4 years
Phase:
NA
Brief Summary
This study investigates under controlled circumstances the concept of THRIVE to improve the ventilation and the carbon dioxide elimination, to prolong the apnoea time without deoxygenation and to impr...
Detailed Description
Eligible, consented children will be prepared for general anaesthesia in the usual way. After start of anesthesia (="induction"), adequate face-mask ventilation will be established. The sealed envelop...
Eligibility Criteria
Inclusion
- paediatric patients undergoing elective surgery requiring general anesthesia with intubation at the University Hospital - Inselspital in Bern.
- ASA physical status 1\&2
- 10-15kg
- legal guardians providing written informed consent.
Exclusion
- known or suspected difficult intubation
- oxygen dependency
- congenital heart or lung disease
- obesity BMI\>20kg/m2
- high aspiration risk (requiring rapid sequence induction intubation).
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03812354
Start Date
January 15 2019
End Date
March 31 2020
Last Update
August 7 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital
Bern, Switzerland, 3010
2
University Hospital Bern
Bern, Switzerland, 3010